title: Insurance and access implications of an over-the-counter switch for a progestin-only pill.
authors.affiliation: Jennifer McIntosh is visiting researcher at the Department of Pharmacy, Hospital Clínic, Barcelona, Spain.
authors.forename: Jennifer
authors.initials: J
authors.lastname: McIntosh
authors.forename: Britt
authors.initials: B
authors.lastname: Wahlin
authors.forename: Kate
authors.initials: K
authors.lastname: Grindlay
authors.forename: Myra
authors.initials: M
authors.lastname: Batchelder
authors.forename: Daniel
authors.initials: D
authors.lastname: Grossman
mesh_terms: D003276:Contraceptives, Oral / Q000008:administration & dosage*; D005260:Female; D018166:Health Care Reform; D006297:Health Services Accessibility; D006801:Humans; D019458:Insurance Coverage; D007348:Insurance, Health; D004366:Nonprescription Drugs / Q000008:administration & dosage*; D011247:Pregnancy; D049168:Pregnancy, Unplanned; D011372:Progestins / Q000008:administration & dosage*; D014481:United States
chemical_list: D003276:Contraceptives, Oral; D004366:Nonprescription Drugs; D011372:Progestins